The Age-related Macular Degeneration pipeline analysis report covers approximately 55 drug candidates in the pipeline in different stages of development.

Many technologies are being developed that can bring the innovative treatment which can control the progression of Age-related macular degeneration. Some of these technologies include but are not limited to, HINGESCREEN technology platform, and CrossMab technology platform.

There are different novel molecule types that are present in the therapeutic pipeline of Age-related macular degeneration. Opregen is being developed by Cell Cure Neurosciences. Opregen is a stem cells molecule type useful in the treatment of Age-related macular degeneration.

Some of the key players developing drugs for Age-related macular degeneration include Formycon, AG, Allergan Plc, Hoffmann-La Roche, and others.

News Courtesy: P&S Market Research

Tagged: Age related Macular Degeneration Treatment Analysis, Age-Related Macular Degeneration, Age-related macular degeneration Therapeutic Pipeline, Age-related macular degeneration Therapeutic Pipeline Analysis, Age-related Macular Degeneration Treatment, AMD Therapeutic Pipeline Analysis